YolTech Therapeutics
YolTech Therapeutics is a pioneering gene editing company dedicated to develop a robust gene editing medicines to treat patients with serious diseases, which has built leading high-throughput evolution platform and innovative LNP deliver system.
$45M Series B+ ·
Led by AstraZeneca-CICC Venture Capital · Source: fundraisingfox.com
Funding history ↓Signals
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Series B+ | $45M | AAstraZeneca-CICC Venture Capital | fundraisingfox.com |
Timeline
- X account created
- Website created
Investors
- AAstraZeneca-CICC Venture Capitallead investor
- CCore Energy Ventures
DDecheng Capital
GGrand Flight Investment
GGreen Pine Capital Partners
GGuoke New Energy Venture Capital
KK2VC
LLoyal Valley Capital
- SShanghai Deyue Touzi Youxian Gongsi
SShanghai Guotou Pioneer
- SShanghai Minjin Investment
- TTianchuang Capital
TTianjin Venture Capital
- YYanying Investment
Companies like YolTech Therapeutics
MMatchpoint Therapeutics$150M Series B+ · Oct 2026
AAlia Therapeutics$5M Seed · Apr 2023LLatus Bio$97M Series A · May 2026
SSpecific Biologics$35M Series A · Nov 2026
RRanomics
NNula Therapeutics$20M Seed · Mar 2026
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/yoltech-therapeutics (get a free API key).